Tuning the physicochemical properties of axitinib by crystallization: Preparation, calculation and Structure-property relationship

被引:7
作者
Qu, Haibin [1 ,3 ]
Li, Zhonghua [1 ]
Zhang, Guimin [2 ]
Zhou, Zongyi [2 ]
Wu, Songgu [1 ,3 ,4 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China
[2] Lunan Pharmaceut Grp Co Ltd, Natl Engn Technol Res Ctr Chiral Pharmaceut, Linyi 276005, Shandong, Peoples R China
[3] Haihe Lab Sustainable Chem Transformat, Tianjin 300192, Peoples R China
[4] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China
基金
中国国家自然科学基金;
关键词
Anticancer drugs; Powder properties; Solid-state chemistry; Multicomponent crystals; Structure-property relationship;
D O I
10.1016/j.jiec.2023.05.014
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Crystal engineering is a radical method to modulate the physicochemical properties of the drugs to meet the needs of the pharmaceutical industry. Examined herein are six axitinib solid-state forms, including anhydrous forms (IV and XLI), solvates (acetic acid, nitromethane and n-propanol), and cocrystal (nicoti-namide). Comprehensive characterization containing morphology, hygroscopicity, solubility, fluores-cence and powder tabletability were performed. Calculations of lattice energy, packing coefficient and energy framework rationalized the structure-property relationship of these six forms from the packing landscape. This system illustrates that form IV and cocrystal improve the solubility of axitinib, but the humidity stability is also decreased. Six crystal forms show polychromatic solid-state luminescence rang -ing from violet to indigo to green. Form IV and cocrystal with slip plane structures exhibited superior ten -sile strength and compactibility than isotropic form XLI. Elusive form VI can be obtained by controlling the humidity levels during desolvation of the solvate. This work not only realizes the regulation of better physicochemical properties of axtinnib for industrial manufacturing, but also provides a detailed under-standing of the structure-property relationship of drugs in complex polymorphic systems. (c) 2023 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:570 / 578
页数:9
相关论文
共 32 条
[1]   Using Cocrystals To Systematically Modulate Aqueous Solubility and Melting Behavior of an Anticancer Drug [J].
Aakeroy, Christer B. ;
Forbes, Safiyyah ;
Desper, John .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (47) :17048-+
[2]   Development of a Targeted Polymorph Screening Approach for a Complex Polymorphic and Highly Solvating API [J].
Campeta, Anthony M. ;
Chekal, Brian P. ;
Abramov, Yuriy A. ;
Meenan, Paul A. ;
Henson, Mark J. ;
Shi, Bing ;
Singer, Robert A. ;
Horspool, Keith R. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (09) :3874-3886
[3]   Crystal Engineering: From Molecule to Crystal [J].
Desiraju, Gautain R. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2013, 135 (27) :9952-9967
[4]   DETERMINATION OF TABLET STRENGTH BY DIAMETRAL-COMPRESSION TEST [J].
FELL, JT ;
NEWTON, JM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (05) :688-&
[5]   Characterisation of organic solid forms and real-time in situ monitoring of their transformations using solid-state fluorescence [J].
Frenette, Mathieu ;
Cosa, Gonzalo ;
Friscic, Tomislav .
CRYSTENGCOMM, 2013, 15 (25) :5100-5106
[6]   Aggregation-induced emission [J].
Hong, Yuning ;
Lam, Jacky W. Y. ;
Tang, Ben Zhong .
CHEMICAL SOCIETY REVIEWS, 2011, 40 (11) :5361-5388
[7]   Facile Tuning of the Photoluminescence and Dissolution Properties of Phloretin through Cocrystallization [J].
Huang, Shan ;
Xu, Jia ;
Peng, Yayun ;
Guo, Minshan ;
Cai, Ting .
CRYSTAL GROWTH & DESIGN, 2019, 19 (12) :6837-6844
[8]   A tolbutamide-metformin salt based on antidiabetic drug combinations: synthesis, crystal structure analysis and pharmaceutical properties [J].
Jia, Lina ;
Wu, Songgu ;
Gong, Junbo .
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2019, 75 :1250-+
[9]   Pharmaceutical cocrystals: from serendipity to design to application [J].
Kavanagh, Oisin N. ;
Croker, Denise M. ;
Walker, Gavin M. ;
Zaworotko, Michael J. .
DRUG DISCOVERY TODAY, 2019, 24 (03) :796-804
[10]   Drug-Bridge-Drug Ternary Cocrystallization Strategy for Antituberculosis Drugs Combination [J].
Liu, Fang ;
Song, Yu ;
Liu, Ya-Nan ;
Li, Yan-Tuan ;
Wu, Zhi-Yong ;
Yan, Cui-Wei .
CRYSTAL GROWTH & DESIGN, 2018, 18 (03) :1283-1286